戻る
Poolbeg Pharma PLC (POLBF)価格
POLBF 株価推移チャート
POLBF 収入
Poolbeg Pharma PLC
$0.04
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.04
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.0425
始値
$0.196
当日レンジ
$0.0425 - $0.196
52週レンジ
$0.042 - $0.196
取引高
460
平均取引高
0
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$29.6M
POLBFとは何ですか？
Poolbeg Pharma Plc is a clinical-stage biopharmaceutical company, which focuses on the development of innovative medicines to address unmet medical needs. The firm is focused on the development of medicines to address unmet medical needs. Its clinical programmes target addressable markets, including cancer immunotherapy-induced Cytokine Release Syndrome (CRS) and metabolic conditions, such as obesity with the development of an oral encapsulated glucagon-like peptide (GLP-1R) agonist. Its pipeline includes POLB 001 Oncology, POLB 001 Influenza, AI Programmes and Oral Encapsulated GLP-1programme. POLB 001 is an orally delivered p38 MAP Kinase inhibitor being developed for the prevention of CRS associated with Bispecific Antibodies and CAR T immunotherapy treatments in cancer. The company uses artificial intelligence to identify infectious disease drug targets & treatments. The Oral Encapsulated GLP-1 programme leverages an advanced delivery system that encapsulates active pharmaceutical ingredients using Generally Regarded as Safe (GRAS) components.